Financial results - X&NMED S.R.L.

Financial Summary - X&Nmed S.r.l.
Unique identification code: 40360050
Registration number: J16/3127/2018
Nace: 8690
Sales - Ron
57.359
Net Profit - Ron
47.706
Employees
1
Open Account
Company X&Nmed S.r.l. with Fiscal Code 40360050 recorded a turnover of 2024 of 57.359, with a net profit of 47.706 and having an average number of employees of 1. The company operates in the field of Alte activitati referitoare la sanatatea umana having the NACE code 8690.
Sales - Ron

Sales, Profit, Employees, Total Income, Financial Results - X&Nmed S.r.l.

2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Sales - EUR - - - - - 0 0 0 19.573 57.359
Total Income - EUR - - - - - 657 6.889 9.163 36.996 73.865
Total Expenses - EUR - - - - - 17.937 25.810 28.590 28.519 24.439
Gross Profit/Loss - EUR - - - - - -17.280 -18.921 -19.427 8.477 49.427
Net Profit/Loss - EUR - - - - - -17.280 -18.921 -19.427 8.282 47.706
Employees - - - - - 3 4 4 3 1
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity as found at the Ministry of Finance. The data provides the evolution of the company during this period regarding the increases and possibly decreases recorded. In the last year of activity, the sales increased by 194.7%, from 19.573 euro in the year 2023, to 57.359 euro in 2024. The Net Profit increased by 39.470 euro, from 8.282 euro in 2023, to 47.706 in the last year.
Sales - Ron
Net Profit - Ron
Employees

Check the financial reports for the company - X&Nmed S.r.l.

Rating financiar

Financial Rating -
X&NMED S.R.L.

See the company's note based on the submitted financial data, relative to the industry of which it is a part.

Financial Rating
Limite de plata

Payment Limits -
X&Nmed S.r.l.

See the company's payment capacity for situations in which you conclude contracts with payment terms.

Check Payment Limits
Probabilitate de insolventa

Prob. of insolvency -
X&Nmed S.r.l.

It determines the risk of insolvency based on the submitted accounting balance.

Insolvency Probability
Rapoarte financiare

Financial Reports -
X&Nmed S.r.l.

Check all the financial reports of the company and know the risks in collaboration with it.

Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.

Debts, Equity, Inventories, Receivables, Accounts, Assets - X&Nmed S.r.l. - CUI 40360050

2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Fixed Assets - - - - - 32.086 27.698 24.096 28.460 64.139
Current Assets - - - - - 42.064 1.187 928 8.775 11.529
Inventories - - - - - 183 179 179 0 0
Receivables - - - - - 41.347 235 260 754 1.912
Cash - - - - - 535 774 489 8.021 9.617
Shareholders Funds - - - - - -18.957 -37.781 -57.326 -48.870 5.178
Social Capital - - - - - 41 40 41 40 40
Debts - - - - - 51.761 32.687 51.952 60.639 54.892
Income in Advance - - - - - 41.347 33.979 30.397 25.466 15.598
Exchange rate - RON 4.9743 4.9465 4.9315 4.9468 4.8371 4.7454 4.6535 4.5681 4.4908 4.445
Main CAEN "8690 - 8690"
CAEN Financial Year 8690
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of 11.529 euro in 2024 which includes Inventories of 0 euro, Receivables of 1.912 euro and cash availability of 9.617 euro.
The company's Equity was valued at 5.178 euro, while total Liabilities amounted to 54.892 euro. Equity increased by 53.775 euro, from -48.870 euro in 2023, to 5.178 in 2024. The Debt Ratio was 72.5% in the year 2024.

Risk Reports Prices

Reviews - X&Nmed S.r.l.

Comments - X&Nmed S.r.l.

Similar services useful for checking companies and business development.

SellNet

Get the contact details for any company and get in touch with it.

Sectoral Studies

Knows the market and develops its own development strategies according to sectorial data.

Databases

Export in excel files the data of the companies selected according to the desired criteria.

Import - Export

Find importers and exporters according to the type of activity and the countries in which they carry it out.

Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.